; and (ii) must have agreed to make such switch after consulting with their physician. (B) Requirements with respect to PDP sponsors The PDP sponsor must— (i) make available a shared savings report with therapeutic alternatives to eligible enrollees through Evidence of Benefits or other information sent to enrollees, or provide contracted providers with access to tools that include therapeutic alternatives and shared savings at the point of care; (ii) ensure that the total amount of savings shared with an enrollee with respect to the switch to a particular lower cost therapeutic alternative covered part D drug does not exceed an amount equal to 10 percent of the annualized net savings to the PDP sponsor as a result of the enrollee making such switch; (iii) only share such savings after the PDP sponsor confirms, based on claims analysis, that— (I) the enrollee has switched to the lower cost therapeutic alternative covered part D drug; and (II) the switch does not result in an increased cost to the program under this part; (iv) provide a tangible reward or incentive for the amount of such shared savings, which— (I) shall directly benefit the enrollee; (II) such sponsor may not— (aa) use to reduce plan premiums for the enrollee; or (bb) direct an enrollee to use to pay such premiums; and (III) may be in the form of a monetary rebate, gift card, discount coupon, or other item consistent with the President’s Executive Order on Protecting and Improving Medicare for Our Nation’s Seniors, issued on October 3, 2019